Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
CERo Therapeutics Holdings ( (CERO) ) has shared an announcement.
On April 8, 2026, CERo Therapeutics Holdings, Inc. issued and sold a $350,000 purchase-price convertible promissory note, with a principal face value of $437,500, to Keystone Capital Partners, LLC, allowing total borrowings of up to $1 million and bearing 10% annual interest until its April 9, 2027 maturity. The note is convertible at the lender’s option into common stock at the lesser of $0.05 per share or 80% of the average of the five lowest intraday trading prices over the prior 20 days, subject to a 4.99% beneficial ownership cap and supported by a planned resale registration filing with the SEC, providing CERo with flexible but potentially dilutive financing through a private, exempt offering to an accredited investor.
The transaction was conducted as a private placement relying on exemptions from registration under Sections 4(a)(2) and 506(b) of the Securities Act, with any conversion shares also expected to rely on similar exemptions, reflecting CERo’s continued use of structured capital solutions to fund its activities. By securing a convertible note with a variable pricing formula tied to market trading levels, the company gains access to incremental funding capacity while signaling a willingness to accept future equity dilution and heightened sensitivity to stock price volatility as it manages its capital structure.
The most recent analyst rating on (CERO) stock is a Hold with a $0.10 price target. To see the full list of analyst forecasts on CERo Therapeutics Holdings stock, see the CERO Stock Forecast page.
More about CERo Therapeutics Holdings
CERo Therapeutics Holdings, Inc. operates in the broader therapeutics and biotechnology sector, with its common stock registered and traded in U.S. markets. The company accesses private capital markets to finance its operations through structured securities, including convertible promissory notes that can be exchanged for common equity under specified conditions.
Average Trading Volume: 480,196
Technical Sentiment Signal: Strong Sell
Current Market Cap: $643.6K
For detailed information about CERO stock, go to TipRanks’ Stock Analysis page.

